17TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY
Kyoto International Conference Center *Kyoto, JAPAN
On behalf of the Organizing Committee it is our great pleasure to invite you to join the 17th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2018) to be held from September 14-16, 2018 in the historic and beautiful city of Kyoto, Japan. IGCS 2018 is being held in collaboration with the Japanese Society of Gynecologic Oncology.
Following the tradition of previous meetings, IGCS 2018 will provide you with the opportunity to learn about the latest clinical advances as well as international developments in research, practice and treatment for the holistic care of women with gynaecological cancer.
The IGCS Biennial Meeting in collaboration with the Japanese Society of Gynecologic Oncology offers a unique program that covers the latest, cutting edge information including innovative developments in surgery, chemotherapy, radiotherapy, and pathology. Translational aspects will be updated and developments in targeted therapies highlighted. The Meeting will also discuss the psycho-social, socio-economic and sexual aspects of gynecological cancer care, as well as palliative and end of life care. Clinical trial updates and unanswered problems will be highlighted within this program. This Meeting is multi-disciplinary and draws on expertise from throughout the world.
An international faculty of world-class experts in gynecological oncology is developing a scientific program that will cover a broad range of topics. We will focus on presenting state-of-the-art lectures and the newest research on relevant topics. A special focus will be given to interactive sessions that give us the opportunity to exchange ideas, form new and maintain existing friendships. Topics related to low and middle income country problems will be addressed extensively including educational challenges and best utilization of limited resources .
Kyoto is the former capital of Japan, located in the Kansai region and has been at the center of traditional Japanese culture for over one thousand years. Harmoniously, Kyoto balances tradition with innovation as the home of cutting edge universities and research institutions. While the city is an important industrial center, Kyoto preserves its historic charm and beauty with its many temples and shrines, parks and gardens and old wooden houses. Kyoto beautifully illustrates the development of Japanese wooden architecture and the art of Japanese gardens, which has influenced landscape gardening throughout the world. This beautiful city is also home to an impressive seventeen World Cultural Heritage Sites including Kiyomizu-dera Temple and Nijo Castle.
Kyoto is also the city of “Omotenashi” (Hospitality), making it a perfect destination for IGCS attendees to gather from around the world. We very much look forward to your participation in IGCS 2018 and to welcoming you to Kyoto, “where tradition meets innovation.” We hope this will be a truly international meeting.
Prof. Michael Quinn
Prof. Keiichi Fujiwara
Chair, IGCS 2018 Scientific Program Committee
Aikou Okamoto (Council, Gyn Onc, Asia/Australia/Oceania)
Department of Ob/Gyn
Jikei University School of Medicine
Keiichi Fujiwara, MD, PhD
Professor and Director
Department of Gynecologic Oncology
Saitama Medical University International Medical Center
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Please follow the instructions listed in this website step-by-step.
Images, tables, diagrams, and graphs must be saved and uploaded as JPEG files. Other file types cannot be accepted. Please note that these may be resized to fit in the final printed material.
If submitting for a Video Presentation - please select the topic Surgical Films - abstracts must be submitted as TEXT like a regular abstract - and if accepted we will advise you with details on how to send in your actual video for onsite presentation.
Abstracts submitted via fax will not be accepted.
No changes can be made to abstracts once they are Final Submitted.
Submission of an abstract acknowledges your acceptance for the abstract to be published in the official meeting publications.
Presenting authors of abstracts must be registered and paid participants. Registration must be received by the Secretariat by the Early Registration Deadline to ensure inclusion of the abstract in the meeting publications and in order to be scheduled for presentation.
Abstracts must be original and must not be or have been published or presented at any other congress prior to the 17th Biennial Meeting of the International Gynecologic Cancer Society.
Abstracts must be submitted in English in the English Topics and Japanese in the Japanese Topics.
Abstracts over 250 words will not be accepted.
Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
The Scientific Committee will determine whether the abstract will be accepted for an Oral Presentation, or a Poster Presentation, with consideration given to the author’s preference.
The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission to the Secretariat.
Abstracts stating “data will be discussed in the presentation” will NOT be accepted.
Your abstract is not successfully submitted until you receive a confirmation e-mail after clicking the final submit button. If you do not receive a confirmation e-mail, please contact email@example.com
Please note the submitting author will receive all correspondence about the abstract so we advise that the submitting author details that are entered at the time of submission match those details as those of the presenting author.
RULES FOR SUBMISSION
The presenting author is expected to attend the conference and present the poster or oral presentation. The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission. Before submitting the abstract, the Abstract Submitter will be required to confirm the following:
1. I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted.
2. Submission of the abstract constitutes my consent to publication (e.g. congress website, programs, other promotions, etc.)
3. The Abstract Submitter warrants and represents that he/she is the sole owner or has the rights of all the information and content (“Content“) provided to the 17th Biennial Meeting of the International Gynecologic Cancer Society. (hereafter: “The Organizers”). The publication of the abstract does not infringe on any third party rights including, but not limited to, intellectual property rights. The Abstract Submitter grants the The Organizers a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the Content.
3a. For US government employees only:
The Abstract Submitter represents that his/her employer is the sole owner or has the rights of all the information and content ("Content") provided to the 17th Biennial Meeting of the International Gynecologic Cancer Society. (hereafter: "The Organizers"). To the best of the Abstract Submitter's knowledge the publication of the abstract does not infringe on any third party rights including, but not limited to, intellectual property rights. The Abstract Submitter grants The Organizers a royalty-free, perpetual, irrevocable nonexclusive right to use, reproduce, publish, translate, distribute, and display the Content for any purpose. The Organizers understand and agree that the Content is a U.S. government work and as such the Content is not subject to copyright protection.
4. The Organizers reserve the right to remove from any publication an abstract that does not comply with the above.
5. I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.
Abstract submission deadline 2018-05-02
Josh Margo , Kenes Group
Josh Margo , Kenes Group